BibbInstruments

BibbInstruments ROA

The Return on Assets (ROA) of BibbInstruments (BIBB.SL) as of Oct 20, 2026 is -36.34 %. In the previous year, Return on Assets (ROA) was -37.68 % — a change of -3.55% (higher).

ROA

-36.34 %

YoY

-3.55%

Last updated:

In 2025, BibbInstruments's return on assets (ROA) was -36.34 %, a -3.55% increase from the -37.68 % ROA in the previous year.

The BibbInstruments ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2018
-27.72 SEK
Jan 1, 2019
-50.34 SEK
Jan 1, 2020
-37.81 SEK
Jan 1, 2021
-43.77 SEK
Jan 1, 2022
-32.40 SEK
Jan 1, 2023
-32.89 SEK
Jan 1, 2024
-37.68 SEK
Jan 1, 2025
-36.34 SEK
The BibbInstruments ROA history
YEARROAYoY
-36.34 %-3.55%
-37.68 %+14.56%
-32.89 %+1.50%
-32.40 %-25.97%
-43.77 %+15.78%
-37.81 %-24.89%
-50.34 %+81.61%
-27.72 %+3.54%
-26.77 %-73,912.55%
0.04 %-80.56%
0.19 %-94.12%
3.18 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

BibbInstruments Stock analysis

What does BibbInstruments do? BiBBInstruments AB generates revenue through the development and sale of diagnostic instruments for early cancer detection, primarily utilizing its EndoDrill technology platform. The company markets specific products including EndoDrill GI Upper for stomach biopsies, EndoDrill GI Lower for intestinal biopsies, EndoDrill GI Lung for lung biopsies, EndoDrill Therapy for organ displacement procedures, EndoDrill Needle for breast biopsies, and EndoDrill Model X for multiple applications. These instruments are sold to hospitals with endoscopy specialist centers and surgical wards, focusing on Scandinavian countries as their primary market. The company's portfolio targets medical professionals requiring precise diagnostic tools for deep skin tissue analysis and treatment procedures. The business model centers on selling specialized biopsy instruments that enable early cancer diagnosis in various organs. EndoDrill GI Upper, GI Lower, and GI Lung are designed for gastrointestinal and respiratory tract biopsies, while EndoDrill Therapy facilitates treatment procedures involving stents and conductors. EndoDrill Needle specifically addresses breast biopsy needs, and EndoDrill Model X serves as an independent research project covering multiple anatomical areas. All products are distributed through hospital networks specializing in endoscopy and surgery. BiBBInstruments AB's revenue streams are derived from direct sales of its diagnostic instrument portfolio to healthcare institutions. The company focuses on Scandinavian countries for distribution, targeting hospitals with specialized endoscopy centers and surgical departments. The EndoDrill technology platform underpins all products, providing a unified approach to early cancer detection and treatment procedures across different medical specialties. BibbInstruments is one of the most popular companies on Eulerpool.

ROA Details

Understanding BibbInstruments's Return on Assets (ROA)

BibbInstruments's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing BibbInstruments's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider BibbInstruments's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in BibbInstruments’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about BibbInstruments stock

Return on Assets (ROA) of BibbInstruments is -36.34 % in 2025.

Return on Assets (ROA) of BibbInstruments changed from -37.68 % to -36.34 %, representing a -3.55% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) BibbInstruments since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s BibbInstruments with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — BibbInstruments

All Key Metrics — BibbInstruments